Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Therapeutic Research - Clinical and Experimental is Scopus-indexed (Q3, CiteScore 3.7), WoS ESCI, DOAJ. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 0011-393XVerify ISSN ↗1879-0313Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 144 / 278 | 48th | Q3 |
| Pharmacology | 190 / 328 | 42nd | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1959–present, best quartile Q3, CiteScore 3.7.
Current Therapeutic Research - Clinical and Experimental is Q3 in Pharmacology (medical) (rank 144 of 278) and Q3 in Pharmacology (rank 190 of 328), by CiteScore 2025.
Current Therapeutic Research - Clinical and Experimental is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.7, which places it in quartile Q3 at the 48th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.609, quartile Q2, with an H-index of 50.
The publisher lists an article processing charge of about US$2,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Current Therapeutic Research - Clinical and Experimental is published by Elsevier Inc. Its print ISSN is 0011-393X and its online ISSN is 1879-0313.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Current Therapeutic Research - Clinical and Experimental has an h-index of 59 and a 2-year mean of 4.14 citations per paper (OpenAlex). Its Scopus CiteScore is 3.7, quartile Q3. On 2-year citations it ranks #44 of 271 Scopus journals in Pharmacology (medical).
Current Therapeutic Research - Clinical and Experimental published 41 papers in 2025; its busiest recent year was 2020 with 47. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2024–2026), authors are most often from Iran (19.1%), China (17.4%) and United States (10.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (1.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.